Delivery Order SPE2DB22D3501-SPE2DB24FVX50
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $27,532.63 firm fixed-price delivery order is for the supply of 4564884356 - DIFICID 200 MG TABLET 20S, with an ultimate completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the drug DIFICID 200 MG TABLET 20S. The contract has a ceiling value of $9,693.77 and an ultimate completion date of July 2, 2025. This award is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of DIFICID 200 MG TABLET 20S. The $40,082.14 Firm Fixed Price contract is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of August 28, 2024. The contract is not designated under any set-aside program. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,819.14 firm fixed-price delivery order is for DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $12,237.25 Firm Fixed Price delivery order to supply the pharmaceutical product DIFICID 200 MG TABLET 20S to the Defense Logistics Agency (DLA). The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $86,209.74 firm fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a prescription medication. The award has an ultimate completion date of August 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $31,352.85 for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price pricing type and a period of performance through April 10, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $19,277.05 for the supply of DIFICID 200 MG TABLET 20S. The contract has an ultimate completion date of November 29, 2023 and was awarded on November 28, 2023. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $26,430.09, is a Delivery Order contract for the DIFICID 200 MG TABLET 20S medication. The contract has an ultimate completion date of December 17, 2024 and a firm fixed price pricing type. This award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (DO) with a Ceiling Value of $5,426.12. The contract is for the supply of the pharmaceutical product DIFICID 200 MG TABLET 20S to the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. The contract has an Ultimate Completion Date of May 12, 2025 and an Award Date of May 9, 2025. Amerisourcebergen Drug Corp also...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVX50Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,755.67 for the supply of DIFICID 200 MG TABLET 20S. The contract, which has a Firm Fixed Price pricing type, was awarded on June 7, 2024 by the Defense Logistics Agency (DLA), a major logistics and supply agency within the Department of Defense (DoD). The contract has an ultimate completion date of June 10, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/7/24 |